company background image
CME

CME Group NasdaqGS:CME Stock Report

Last Price

US$191.67

Market Cap

US$68.9b

7D

-2.2%

1Y

-10.8%

Updated

24 May, 2022

Data

Company Financials +
CME fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance3/6
Financial Health5/6
Dividends3/6

CME Stock Overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.

CME Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CME Group
Historical stock prices
Current Share PriceUS$191.67
52 Week HighUS$256.94
52 Week LowUS$185.79
Beta0.47
1 Month Change-14.02%
3 Month Change-18.63%
1 Year Change-10.80%
3 Year Change2.36%
5 Year Change63.54%
Change since IPO2,133.92%

Recent News & Updates

Apr 30

Why CME Should Be In Our Dividend Growth Portfolios

CME Group is a great mix between growth and value as it offers a good yield and long-term (expected) outperformance. Because of its business model, the company is able to generate high free cash flow used to distribute a high yield as its healthy balance sheet needs no attention. The valuation is getting good, and I'm planning on using market weakness to add it to my dividend growth portfolio.

Apr 15
Is Now The Time To Put CME Group (NASDAQ:CME) On Your Watchlist?

Is Now The Time To Put CME Group (NASDAQ:CME) On Your Watchlist?

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Shareholder Returns

CMEUS Capital MarketsUS Market
7D-2.2%-0.9%-4.0%
1Y-10.8%-14.0%-13.2%

Return vs Industry: CME exceeded the US Capital Markets industry which returned -13.5% over the past year.

Return vs Market: CME exceeded the US Market which returned -12.3% over the past year.

Price Volatility

Is CME's price volatile compared to industry and market?
CME volatility
CME Average Weekly Movement4.6%
Capital Markets Industry Average Movement0.5%
Market Average Movement7.8%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market2.9%

Stable Share Price: CME is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: CME's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18983,480Terry Duffyhttps://www.cmegroup.com

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services.

CME Group Fundamentals Summary

How do CME Group's earnings and revenue compare to its market cap?
CME fundamental statistics
Market CapUS$68.89b
Earnings (TTM)US$2.74b
Revenue (TTM)US$4.77b

25.1x

P/E Ratio

14.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CME income statement (TTM)
RevenueUS$4.77b
Cost of RevenueUS$0
Gross ProfitUS$4.77b
Other ExpensesUS$2.03b
EarningsUS$2.74b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)7.64
Gross Margin100.00%
Net Profit Margin57.51%
Debt/Equity Ratio12.4%

How did CME perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

48%

Payout Ratio

Does CME pay a reliable dividends?

See CME dividend history and benchmarks
When do you need to buy CME by to receive an upcoming dividend?
CME Group dividend dates
Ex Dividend DateJun 09 2022
Dividend Pay DateJun 27 2022
Days until Ex dividend14 days
Days until Dividend pay date32 days

Does CME pay a reliable dividends?

See CME dividend history and benchmarks

Valuation

Is CME Group undervalued compared to its fair value and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


25.1x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: CME ($191.67) is trading above our estimate of fair value ($181.31)

Significantly Below Fair Value: CME is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CME is good value based on its Price-To-Earnings Ratio (25.1x) compared to the US Capital Markets industry average (30.5x).

PE vs Market: CME is poor value based on its Price-To-Earnings Ratio (25.1x) compared to the US market (15.1x).


Price to Earnings Growth Ratio

PEG Ratio: CME is poor value based on its PEG Ratio (3.5x)


Price to Book Ratio

PB vs Industry: CME is overvalued based on its Price-To-Book Ratio (2.5x) compared to the US Capital Markets industry average (-17.7x).


Future Growth

How is CME Group forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


7.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CME's forecast earnings growth (7.2% per year) is above the savings rate (1.9%).

Earnings vs Market: CME's earnings (7.2% per year) are forecast to grow slower than the US market (12.3% per year).

High Growth Earnings: CME's earnings are forecast to grow, but not significantly.

Revenue vs Market: CME's revenue (5.5% per year) is forecast to grow slower than the US market (7.8% per year).

High Growth Revenue: CME's revenue (5.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CME's Return on Equity is forecast to be low in 3 years time (10.9%).


Past Performance

How has CME Group performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-4.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CME has high quality earnings.

Growing Profit Margin: CME's current net profit margins (57.5%) are higher than last year (41.6%).


Past Earnings Growth Analysis

Earnings Trend: CME's earnings have declined by 4.1% per year over the past 5 years.

Accelerating Growth: CME's earnings growth over the past year (43.4%) exceeds its 5-year average (-4.1% per year).

Earnings vs Industry: CME earnings growth over the past year (43.4%) underperformed the Capital Markets industry 98.3%.


Return on Equity

High ROE: CME's Return on Equity (10%) is considered low.


Financial Health

How is CME Group's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CME's short term assets ($171.0B) exceed its short term liabilities ($168.5B).

Long Term Liabilities: CME's short term assets ($171.0B) exceed its long term liabilities ($9.7B).


Debt to Equity History and Analysis

Debt Level: CME's net debt to equity ratio (4.6%) is considered satisfactory.

Reducing Debt: CME's debt to equity ratio has increased from 10.9% to 12.4% over the past 5 years.

Debt Coverage: CME's debt is well covered by operating cash flow (75.6%).

Interest Coverage: CME earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is CME Group current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


3.78%

Current Dividend Yield

Upcoming Dividend Payment

TodayMay 25 2022Ex Dividend DateJun 09 2022Dividend Pay DateJun 27 202218 days from Ex DividendBuy in the next 14 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: CME's dividend (3.78%) is higher than the bottom 25% of dividend payers in the US market (1.57%).

High Dividend: CME's dividend (3.78%) is low compared to the top 25% of dividend payers in the US market (4.05%).


Stability and Growth of Payments

Stable Dividend: CME's dividend payments have been volatile in the past 10 years.

Growing Dividend: CME's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (48.3%), CME's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (105.2%), CME's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

11.3yrs

Average management tenure


CEO

Terry Duffy (63 yo)

5.5yrs

Tenure

US$22,924,737

Compensation

Mr. Terrence A. Duffy, also known as Terry, has been Chief Executive Officer and Chairman at CME Group Inc since November 15, 2016. Mr. Duffy is the Chief Executive Officer at New York Mercantile Exchange,...


CEO Compensation Analysis

Compensation vs Market: Terry's total compensation ($USD22.92M) is above average for companies of similar size in the US market ($USD13.26M).

Compensation vs Earnings: Terry's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: CME's management team is seasoned and experienced (11.3 years average tenure).


Board Members

Experienced Board: CME's board of directors are seasoned and experienced ( 17 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CME insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

CME Group Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: CME Group Inc.
  • Ticker: CME
  • Exchange: NasdaqGS
  • Founded: 1898
  • Industry: Financial Exchanges and Data
  • Sector: Diversified Financials
  • Implied Market Cap: US$68.890b
  • Shares outstanding: 359.42m
  • Website: https://www.cmegroup.com

Number of Employees


Location

  • CME Group Inc.
  • 20 South Wacker Drive
  • Chicago
  • Illinois
  • 60606
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/24 00:00
End of Day Share Price2022/05/24 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.